Trial intelligence / Profile preview

Fluoride Therapies for Hypersensitive Carious Lesions in Primary Teeth

NCT04804423Phase 3Completed

Sponsor
Universitätsklinikum Greifswald
Start
Jan 2020
Primary completion
Mar 2021
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of silver diamine fluoride + potassium iodide in dentin hypersensitivity (DH), dental caries, sponsored by Universitätsklinikum Greifswald. Started Jan 2020; status: completed.

02

Drugs

silver diamine fluoride + potassium iodide
03

Conditions

dentin hypersensitivity (DH)dental caries

Beyond the preview

Go deeper on NCT04804423.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04804423.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call